Amyloid-β — a reflection of risk or a preclinical marker?

Amyloid-β — a reflection of risk or a preclinical marker?

Amyloid-β — a reflection of risk or a preclinical marker?, Published online: 30 April 2018; doi:10.1038/s41582-018-0008-9

In a recent study, individuals with brain amyloid-β accumulation but no cognitive impairment were classified as being at risk of Alzheimer disease, yet amyloid-β is widely considered to be a pathological biomarker of Alzheimer disease rather than a risk factor — it cannot be both.

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader https://ift.tt/2FtfiWZ